SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-18-045947
Filing Date
2018-02-14
Accepted
2018-02-14 17:22:11
Documents
3
Group Members
SV LIFE SCIENCES FUND V (GP), L.P.SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.SV LIFE SCIENCES FUND V, L.P.SV LIFE SCIENCES FUND VI (GP), L.P.SV LIFE SCIENCES FUND VI STRATEGIC PARTNERS, L.P.SV LIFE SCIENCES FUND VI, LP.SVLSF VI, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d537004dsc13d.htm SC 13D 185161
2 EX-99.1 d537004dex991.htm EX-99.1 13707
3 EX-99.2 d537004dex992.htm EX-99.2 23806
  Complete submission text file 0001193125-18-045947.txt   224574
Mailing Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451 781-819-5704
Arsanis, Inc. (Subject) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90199 | Film No.: 18613773
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SV LIFE SCIENCES ADVISERS, LLC ONE BOSTON PLACE, SUITE 3900 BOSTON MA 02108
Business Address C/O SV LIFE SCIENCES ADVISERS, LLC ONE BOSTON PLACE, SUITE 3900 BOSTON MA 02108 617-367-8100
SVLSF V, LLC (Filed by) CIK: 0001644160 (see all company filings)

IRS No.: 264430055 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D